Li et al. showed that CD112R deficiency or treatment with blocking mAbs against CD112R protected mice against subcutaneous MC38 tumors, and this was associated with increased degranulation and IFN-γ production by tumor-infiltrating NK cells [73]. Here, PVRIG is linked to neoplasm.